<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The chromosome der(1;7) (q10;p10) is a derivative chromosome consisting of the short arm of chromosome 7 and the long arm of chromosome 1 </plain></SENT>
<SENT sid="1" pm="."><plain>We observed this abnormality in three patients with <z:hpo ids='HP_0004808'>acute myeloblastic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), or <z:hpo ids='HP_0005547'>myeloproliferative disorder</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Case 1 was a 76-yr-old male with a history of IgG <z:mp ids='MP_0009440'>myeloma</z:mp> treated with melphalan, <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, <z:chebi fb="0" ids="28445">vincristine</z:chebi>, and <z:chebi fb="2" ids="8378">prednisolone</z:chebi> (MEVP) </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M1 developed one and half years after discontinuation of the MEVP therapy </plain></SENT>
<SENT sid="4" pm="."><plain>Case 2 was a 39-yr-old male with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Case 3 was a 56-yr-old male with <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts in transformation that evolved from primary <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Chromosome analyses revealed der(1;7) (q10;p10) in bone marrow cells of the three patients </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients failed to respond to chemotherapy, and died within four months after the diagnosis </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, der (1;7) (q10;p10) may indicate a very poor prognostic outcome in patients with malignant <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorders</z:e> </plain></SENT>
</text></document>